1-2 of 2
Jennifer C. Stern
Close
Sort by
Journal Articles

Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemia

Clinical Trials & Observations
Constantine S. Tam, Judith Trotman, Stephen Opat, Jennifer C. Stern, Heather Allewelt, Kunthel By, William Novotny, Jane Huang, Alessandra Tedeschi
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2884–2887.
https://doi.org/10.1182/bloodadvances.2022008990
Published: 2023
Includes: Supplemental data
Journal Articles

Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma

Clinical Trials & Observations
Tycel Phillips, Henry Chan, Constantine S. Tam, Alessandra Tedeschi, Patrick Johnston, Sung Yong Oh, Stephen Opat, Hyeon-Seok Eom, Heather Allewelt, Jennifer C. Stern, Ziwen Tan, William Novotny, Jane Huang, Judith Trotman
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3472–3479.
https://doi.org/10.1182/bloodadvances.2021006083
Published: 2022
Includes: Supplemental data